(Q64140153)
Statements
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites (English)
0 references
2 November 2015
0 references
26 May 2016
0 references
2
0 references
18 year
0 references